Skip to main content
Displaying 1 - 7 of 7
Display:
12
24
48
Metabolism, Alcohol & Toxicity
3
Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021
View
Metabolism, Alcohol & Toxicity
3
Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021
View
Metabolism, Alcohol & Toxicity
3
Siemens: Non-Invasive Assessment of Liver Fibrosis in Chronic Liver Diseases - ILC 2021
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
Metabolism, Alcohol & Toxicity
4
Intercept: Emerging trends in the care pathway for patients with NASH - Digital ILC 2020
View
©2019 - EASL. All Rights Reserved. Powered by
Enovation
.
Footer menu
Content Access policy
Privacy Policy
Cookie Policy